Combined anti‐inflammatory and low‐dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. (2nd September 2019) - Reimer, A.; Lu, S.; He, Y.; Bruckner‐Tuderman, L.; Technau‐Hafsi, K.; Meiss, F.; Has, C.; von Bubnoff, D.